Federal update: DOJ partially rescheduled medical cannabis to Schedule III (April 28, 2026 final order). State-licensed medical operators may apply for expedited DEA registration through June 27, 2026; DEA hearing on full rescheduling set for June 29, 2026.

Disclaimer

CannabisGlossary.org is an independent educational reference. It provides encyclopedic definitions of cannabis terminology. It does not constitute — and should not be relied upon as — medical, legal, pharmaceutical, or financial advice.

Not medical advice

Definitions of medical conditions, drug interactions, and pharmaceutical products are provided for informational purposes only. Always consult a licensed healthcare professional before making decisions about cannabis use, especially if you take prescription medications or have a chronic health condition.

Not legal advice

Legal definitions reflect the state of federal and state law as of April 2026. Cannabis law changes frequently. Consult a qualified attorney for advice about your specific jurisdiction and circumstances. Cannabis remains a Schedule I controlled substance under U.S. federal law regardless of state legalization.

No product endorsement

We sell no products, accept no advertising, and have no financial relationship with dispensaries, brands, or product manufacturers. Mention of specific products, strains, or companies is for definitional accuracy only.

Disputed terms

Terms flagged with ⚠️ have definitions that are scientifically, taxonomically, or legally contested. The dispute is explained in the definition itself. We present the competing positions rather than adjudicating them.

Accuracy and currency

We make every effort to ensure definitions are accurate, current, and properly sourced. If you find an error, please contact us.